Your browser version may not work well with NCBI's Web applications. More information here...
Items 1 - 20 of 875
of 44Next
1:

Effects of intranasal TNFalpha on granulocyte recruitment and activity in healthy subjects and patients with allergic rhinitis.

Widegren H, Erjefält J, Korsgren M, Andersson M, Greiff L.

Respir Res. 2008 Jan 30;9:15.

PMID: 18234086 [PubMed - indexed for MEDLINE]

2:

Effects of TNFalpha on the human nasal mucosa in vivo.

Widegren H, Korsgren M, Andersson M, Greiff L.

Respir Med. 2007 Sep;101(9):1982-7. Epub 2007 May 25.

PMID: 17532197 [PubMed - indexed for MEDLINE]

3:

Effect of six-hour exposure to nitrogen dioxide on early-phase nasal response to allergen challenge in patients with a history of seasonal allergic rhinitis.

Wang JH, Devalia JL, Duddle JM, Hamilton SA, Davies RJ.

J Allergy Clin Immunol. 1995 Nov;96(5 Pt 1):669-76.

PMID: 7499684 [PubMed - indexed for MEDLINE]

4:

Alpha2-macroglobulin and eosinophil cationic protein in the allergic airway mucosa in seasonal allergic rhinitis.

Meyer P, Persson CG, Andersson M, Wollmer P, Linden M, Svensson C, Greiff L.

Eur Respir J. 1999 Mar;13(3):633-7.

PMID: 10232439 [PubMed - indexed for MEDLINE]

5:

Loratadine reduces allergen-induced mucosal output of alpha 2-macroglobulin and tryptase in allergic rhinitis.

Greiff L, Persson CG, Svensson C, Enander I, Andersson M.

J Allergy Clin Immunol. 1995 Jul;96(1):97-103.

PMID: 7542675 [PubMed - indexed for MEDLINE]

6:

Steroid-sensitive indices of airway inflammation in children with seasonal allergic rhinitis.

Meyer P, Andersson M, Persson CG, Greiff L.

Pediatr Allergy Immunol. 2003 Feb;14(1):60-5.

PMID: 12603713 [PubMed - indexed for MEDLINE]

7:

Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.

Gosset P, Tillie-Leblond I, Malaquin F, Durieu J, Wallaert B, Tonnel AB.

Clin Exp Allergy. 1997 Apr;27(4):379-88.

PMID: 9146930 [PubMed - indexed for MEDLINE]

8:

Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment.

Greiff L, Petersen H, Mattsson E, Andersson M, Erjefält JS, Linden M, Svensson C, Persson CG.

Clin Exp Allergy. 2001 Aug;31(8):1321-7.

PMID: 11529904 [PubMed - indexed for MEDLINE]

9:

Eosinophil degranulation status in allergic rhinitis: observations before and during seasonal allergen exposure.

Ahlstrom-Emanuelsson CA, Greiff L, Andersson M, Persson CG, Erjefält JS.

Eur Respir J. 2004 Nov;24(5):750-7.

PMID: 15516668 [PubMed - indexed for MEDLINE]

10:

Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.

Greiff L, Persson CG, Andersson M.

Ann Allergy Asthma Immunol. 2002 Oct;89(4):413-8.

PMID: 12392387 [PubMed - indexed for MEDLINE]

11:

The effect of recombinant interleukin-8 on eosinophils' and neutrophils' migration in vivo and in vitro.

Bocheńska-Marciniak M, Kupczyk M, Górski P, Kuna P.

Allergy. 2003 Aug;58(8):795-801.

PMID: 12859561 [PubMed - indexed for MEDLINE]

12:

Nasal response to a single antigen challenge in patients with allergic rhinitis - inflammatory cell recruitment persists up to 48 hours.

Miadonna A, Milazzo N, Gibelli S, Salmaso C, Lorini M, Tedeschi A.

Clin Exp Allergy. 1999 Jul;29(7):941-9.

PMID: 10383595 [PubMed - indexed for MEDLINE]

13:

Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge.

Ciprandi G, Tosca MA, Passalacqua G, Canonica GW.

Ann Allergy Asthma Immunol. 2001 Apr;86(4):433-8.

PMID: 11345288 [PubMed - indexed for MEDLINE]

14:

Effects of orally inhaled budesonide in seasonal allergic rhinitis.

Greiff L, Andersson M, Svensson C, Linden M, Wollmer P, Brattsand R, Persson CG.

Eur Respir J. 1998 Jun;11(6):1268-73.

PMID: 9657565 [PubMed - indexed for MEDLINE]

15:

Nasal neutrophil activity and mucinous secretory responsiveness in COPD.

Nihlén U, Andersson M, Löfdahl CG, Persson CG, Montnémery P, Greiff L.

Clin Physiol Funct Imaging. 2003 May;23(3):138-42.

PMID: 12752555 [PubMed - indexed for MEDLINE]

16:

A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin-5.

Beeh KM, Beier J, Kornmann O, Meier C, Taeumer T, Buhl R.

Clin Exp Allergy. 2003 Apr;33(4):475-82.

PMID: 12680863 [PubMed - indexed for MEDLINE]

17:

Allergen challenge-induced acute exudation of IL-8, ECP and alpha2-macroglobulin in human rhinovirus-induced common colds.

Greiff L, Andersson M, Svensson C, Linden M, Myint S, Persson CG.

Eur Respir J. 1999 Jan;13(1):41-7.

PMID: 10836321 [PubMed - indexed for MEDLINE]

18:

Eosinophil markers in seasonal allergic rhinitis. Intranasal fluticasone propionate inhibits local and systemic increases during the pollen season.

Nielsen LP, Bjerke T, Christensen MB, Skamling M, Peterson CG, Mygind N, Dahl R.

Allergy. 1998 Aug;53(8):778-85.

PMID: 9722227 [PubMed - indexed for MEDLINE]

19:

IL-8 and the activation of eosinophils and neutrophils following nasal allergen challenge.

Jacobi HH, Poulsen LK, Reimert CM, Skov PS, Ulfgren AK, Jones I, Elfman LB, Malling HJ, Mygind N.

Int Arch Allergy Immunol. 1998 May;116(1):53-9.

PMID: 9623510 [PubMed - indexed for MEDLINE]

20:

[Myeloperoxidase (MPO) as a marker of neutrophil influx into nasal mucosa after recombinant IL-8 challenge]

Kupczyk M, Bocheńska-Marciniak M, Górski P, Kuna P.

Pneumonol Alergol Pol. 2002;70(11-12):544-9. Polish.

PMID: 12884563 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 875
of 44Next